Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phentermine + Satiete is a combination therapy used for weight loss, consisting of the prescription medication phentermine and the herbal product Satiete. Phentermine is a sympathomimetic amine anorectic agent that acts as an appetite suppressant by stimulating the release of norepinephrine in the hypothalamus, thereby reducing hunger. Satiete is an herbal supplement included to potentially enhance weight loss effects, though its precise mechanism and active ingredients are not well characterized in published literature. This combination has been studied in clinical practice settings for short-term management of obesity, with reported efficacy in promoting modest weight reduction over several weeks[1]. The safety profile appears acceptable based on limited observational data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phentermine + Satiete.